Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01445210
Other study ID # 2011-0184
Secondary ID
Status Completed
Phase N/A
First received September 29, 2011
Last updated October 18, 2012
Start date September 2011
Est. completion date October 2012

Study information

Verified date October 2012
Source University of Aarhus
Contact n/a
Is FDA regulated No
Health authority Denmark: Danish Dataprotection Agency
Study type Interventional

Clinical Trial Summary

The most useful method to manage pain after major ankle surgery is infusion of local analgesics with a catheter close to the sciatic nerve.

Sensation from the ankle are carried by three nerves: The tibial and peroneal nerve (unified in the sciatic nerve) and the saphenous nerve.

Study purpose is to test whether continuous infusion of local analgesics by saphenous nerve catheter provide a better treatment of pain in comparison with a single injection nerve block. In addition cost-effectiveness of the two methods are compared.

The 50 patients of the trial are randomized in clusters of ten. We intend to do a preliminary analysis of the data from the first 40 patients. However, it is not an interim analysis. Fifty patients will be included independent of the result of the preliminary analysis. The random allocation of the last 10 patients will also be double-blinded.


Description:

Major ankle surgery are known to be very painful the first 48 hours after the operation due to surgical oedema. This pain is difficult to control with systemic analgesics. Pain relief with systemic analgesics requires high doses of intravenous opioids and is associated with breakthrough pain and adverse effects of opioids (sedation, nausea, vomiting, obstipation, urinary retention, respiratory depression).

Continuous, peripheral nerve block with catheter technique for two days minimizes the need for systemic analgesics. Today such a continuous sciatic nerve block is part of the standard pain treatment after major ankle surgery on Aarhus University Hospital. Despite accurate placement of the catheter many patients are in great pain because the saphenous nerve remain unaffected. A single injection block relieve the pain but a block with Ropivacaine only last 8-15 hours.

Severe postoperative pain leads to high opioid dosages, cognitive blurring, nausea, vomiting, reduced ambulation, increased surgical stress response and increased morbidity. Pain problems and adverse effects prolongs postoperative observation time and maybe also time to discharge.

The aim of the study establish whether continuous saphenous nerve block is efficient (pain relief or reduced opioid consumption) and justified (cost-effectiveness analysis) compared with single injection block.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date October 2012
Est. primary completion date October 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria: Elective major ankle surgery

- total ankle arthroplasty

- subtalar fusion

- ankle fusion (non arthroscopic)

Exclusion Criteria:

- coagulation abnormalities

- infection in the region of needle insertion

- systemic infection

- preoperative consumption of high dose opioid

- preoperative sciatic or femoral nerve neuropathy

- preoperative sensory deficit in either of the lower extremities

- Charcot-Marie-Tooth disorder

- diabetic neuropathy

- severe peripheral vascular disease

- allergy to local anesthetics

- lack of understanding of Numeric Rank Scale (NRS)

- communication problems

- dementia

- body mass index above 35

- bilateral continuous sciatic nerve block

- lack of consent

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Continuous saphenous nerve block
0,2% Ropivacaine by elastomeric infusion pump at 5 ml/h for 48 postoperative hours
Placebo
Isoton saline by elastomeric infusion pump at 5 ml/h for 48 postoperative hours

Locations

Country Name City State
Denmark Aarhus University Hospital Aarhus

Sponsors (2)

Lead Sponsor Collaborator
University of Aarhus Aarhus University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Accumulated opioid consumption First 48 hours postoperative No
Secondary Success rate for saphenous nerve analgesia Pain rated by NRS and opioid consumption Postoperative, first 48 hours No
Secondary Success rate for clinical analgesia of foot and ankle Pain rated by NRS and opioid consumption Postoperative, first 48 hours No
Secondary Success rate for tibial and peroneal nerve block Pain rated by NRS and test of sensation on the toes Postoperative, first 48 hours No
Secondary Localisation of worst pain Postoperative, first 48 hours No
Secondary Cost-effectiveness 2 first postoperative days No